GLSI Operating Cash Flow (Statement)

Greenwich Lifesciences Inc · Operating Cash Flow (Statement)

GLSI logo

GLSI Operating Cash Flow (Statement)

Latest reported-$1.94M
GLSI Quarterly Cash from Operations (-$80.00K → -$1.94M)
High-resolution chart · PNG

GLSI operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Greenwich Lifesciences Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-1,939,746
-4,702,498
-3,174,657
-2,671,239
-2,233,103
-1,834,454
-1,852,206
-2,583,932
-1,047,840
-1,782,565
-2,154,195
-1,800,623
-966,977
-1,556,807
-2,170,061
-1,549,803
-532,701
-1,947,462
-2,264,320
-894,639
-604,319
-528,270
-1,152,962
0
0
0
-214,167
900
0
-80,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.